SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 52.73-1.5%12:40 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (4867)10/31/2001 3:04:59 PM
From: Icebrg  Read Replies (1) of 52153
 
NBIX and NPSP

I note that the two companies are trading at about the same market cap. Just shy of 1.100 mUSD. To me this seems to be somewhat flattering for NPSP. They have a promising pipeline of drugs, but not at all the same depth as NBIX. That is at least what I believe. What could be the reason behind the richer valuation of NPSP? (If it indeed is richer).

Ice
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News